215 related articles for article (PubMed ID: 10731882)
1. [Therapy of venous thromboembolism with low-molecular-weight heparins].
Haas S; Haas P; Creutzig A
Vasa; 2000 Feb; 29(1):5-10. PubMed ID: 10731882
[TBL] [Abstract][Full Text] [Related]
2. [Therapy of thromboses with low-molecular-weight heparins].
Haas S; Haas P
Wien Med Wochenschr; 1999; 149(2-4):39-45; discussion 45. PubMed ID: 10378321
[TBL] [Abstract][Full Text] [Related]
3. Low-molecular-weight heparin: prophylaxis and treatment of venous thromboembolism.
Pineo GF; Hull RD
Annu Rev Med; 1997; 48():79-91. PubMed ID: 9046947
[TBL] [Abstract][Full Text] [Related]
4. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism.
van Den Belt AG; Prins MH; Lensing AW; Castro AA; Clark OA; Atallah AN; Burihan E
Cochrane Database Syst Rev; 2000; (2):CD001100. PubMed ID: 10796593
[TBL] [Abstract][Full Text] [Related]
5. [Treatment and prophylaxis of deep venous thrombosis with low molecular weight heparins (meta-analysis of clinical trials)].
Valiukiene L; Naudziūnas A; Unikauskas A
Medicina (Kaunas); 2003; 39(4):352-8. PubMed ID: 12738903
[TBL] [Abstract][Full Text] [Related]
6. Low-molecular-weight heparin in the treatment of pulmonary embolism.
Ageno W; Turpie AG
Semin Vasc Surg; 2000 Sep; 13(3):189-93. PubMed ID: 11005462
[TBL] [Abstract][Full Text] [Related]
7. Treatment of deep vein thrombosis with low-molecular-weight heparins: a consensus statement of the Gesellschaft für Thrombose-und Hämostaseforschung (GTH).
Harenberg J; Schmitz-Huebner U; Breddin KH; Hass S; Heinrich F; Heinrichs C; Kienast J; Roebruck P; Theiss W; Wenzel E
Semin Thromb Hemost; 1997; 23(1):91-6. PubMed ID: 9156416
[TBL] [Abstract][Full Text] [Related]
8. Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis.
Breddin HK; Hach-Wunderle V; Nakov R; Kakkar VV;
N Engl J Med; 2001 Mar; 344(9):626-31. PubMed ID: 11228276
[TBL] [Abstract][Full Text] [Related]
9. Dosage, anticoagulant, and antithrombotic effects of heparin and low-molecular-weight heparin in the treatment of deep vein thrombosis.
Harenberg J; Stehle G; Blauth M; Huck K; Mall K; Heene DL
Semin Thromb Hemost; 1997; 23(1):83-90. PubMed ID: 9156415
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of proximal deep venous thrombosis of the legs by low-molecular-weight heparin: a systematic review].
Lamy O; Cornuz J; Yersin B
Schweiz Med Wochenschr; 1999 May; 129(18):707-14. PubMed ID: 10407944
[TBL] [Abstract][Full Text] [Related]
11. Low-molecular-weight heparins for the treatment of deep-vein thrombosis.
Cziraky MJ; Spinler SA
Clin Pharm; 1993 Dec; 12(12):892-9. PubMed ID: 8137606
[TBL] [Abstract][Full Text] [Related]
12. Heparin and low-molecular-weight heparin therapy for venous thromboembolism. The twilight of anticoagulant monitoring.
Hull RD; Pineo GF; Stein P
Int Angiol; 1998 Dec; 17(4):213-24. PubMed ID: 10204652
[TBL] [Abstract][Full Text] [Related]
13. Unfractionated and low-molecular-weight heparin. Comparisons and current recommendations.
Pineo GF; Hull RD
Med Clin North Am; 1998 May; 82(3):587-99. PubMed ID: 9646781
[TBL] [Abstract][Full Text] [Related]
14. Outpatient therapy with low-molecular-weight heparins: new perspectives for treatment of deep vein thrombosis.
Büller HR
Haemostasis; 1998; 28 Suppl 3():91-4. PubMed ID: 10069767
[TBL] [Abstract][Full Text] [Related]
15. Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis--an economic evaluation. TASMAN Study Group.
van den Belt AG; Bossuyt PM; Prins MH; Gallus AS; Büller HR
Thromb Haemost; 1998 Feb; 79(2):259-63. PubMed ID: 9493572
[TBL] [Abstract][Full Text] [Related]
16. [Anticoagulation in patients with venous thromboembolism].
Rüfer A; Wuillemin WA
Ther Umsch; 2003 Jan; 60(1):43-7. PubMed ID: 12638478
[TBL] [Abstract][Full Text] [Related]
17. Unfractionated versus low-molecular-weight heparin for deep venous thrombosis.
Strandness DE
N Engl J Med; 1996 Aug; 335(9):670-1; author reply 671-2. PubMed ID: 8692246
[No Abstract] [Full Text] [Related]
18. [Treatment of venous thrombosis with low molecular weight heparin. Progress and outlook].
Fiessinger JN
Bull Acad Natl Med; 1997 May; 181(5):875-83; discussion 883-5. PubMed ID: 9312362
[TBL] [Abstract][Full Text] [Related]
19. Unfractionated versus low-molecular-weight heparin for deep venous thrombosis.
Penner J
N Engl J Med; 1996 Aug; 335(9):671; author reply 671-2. PubMed ID: 8692247
[No Abstract] [Full Text] [Related]
20. The role of low molecular weight heparin in total knee arthroplasty.
Iobst CA; Friedman RJ
Am J Knee Surg; 1999; 12(1):55-60. PubMed ID: 10050695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
